Skip to Content

MAVENCLAD 10 mg tablets

Licence status
Authorised: 22/08/2017
Active substances
Cladribine
Dosage Form
Tablet
Licence number
EU/1/17/1212/001-006
Licence holder
Merck Europe B.V.

Licence information

ATC code
L04AA Selective immunosuppressants
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/08/2017